Abstract
Objective
To evaluate the feasibility and effectiveness of single ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation in managing placenta accreta spectrum (PAS) disorder.
Materials and methods
We retrospectively analyzed 40 PAS patients between April 2017 and October 2021. All the patients received one session of HIFU treatment. Regular follow-up was done after HIFU treatment until normal menstruation returned and placental tissue disappeared. The patient’s reproductive-related outcomes were obtained through telephone interviews.
Results
The median follow-up time for the 40 patients was 30.50 (15.75–44.00) months and the mean placental tissue elimination time was 45.29 ± 33.32 days. The mean duration of bloody lochia was 13.43 ± 10.01 days, with no incidences of severe bleeding. Notably, Linear regression analysis showed that the residual placenta volume before HIFU was a factor affecting the duration of bloody lochia after HIFU (R2 = 0.284, B = 0.062, P = 0.000). The normal menstrual return time was 58.71 ± 31.14 days. One (2.50%) patient developed an infection. Two (5.00%) patients were subjected to ultrasound-guided suction curettage for persistent vaginal discharge for more than one month without infection. Notably, 7 of the 18 patients who expressed reproductive plans became pregnant during the 4 to 53 months of follow-up without placental abnormalities. The remaining 11 patients were on contraceptives.
Conclusions
Single HIFU is an effective treatment option for managing PAS. However, future studies on further treatment strategies to reduce complications and promote patient recovery after HIFU ablation are desirable.
Similar content being viewed by others
References
Cheong JY, Kong TW, Son JH et al (2014) Outcome of pelvic arterial embolizafion for postpartum hemorrhage: A retrospective review of 117 cases[J ]. Obstet Gynecol Sci 57(1):17–27. https://doi.org/10.5468/ogs.2014.57.1.17
Gu Y, Zhou Y, Li L, Li H, Wang S, Wang Y, Zuo C (2022) Cook Cervical Ripening Balloon for placenta accreta spectrum disorders with placenta previa: a novel approach to uterus preserving. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-022-06476-6
Youssefzadeh AC, Matsuzaki S, Mandelbaum RS, Sangara RN, Bainvoll L, Matsushima K, Ouzounian JG, Matsuo K (2022) Trends, characteristics, and outcomes of conservative management for placenta percreta. Arch Gynecol Obstet 306(3):913–920. https://doi.org/10.1007/s00404-021-06384-1
Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E (2018) FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 140(3):291–298. https://doi.org/10.1002/ijgo.12410
Lin K, Qin J, Xu K, Hu W, Lin J (2015) Methotrexate management for placenta accreta: a prospective study. Arch Gynecol Obstet 291(6):1259–1264. https://doi.org/10.1007/s00404-014-3573-1
Legendre G, Zoulovits FJ, Kinn J, Senthiles L, Fernandez H (2014) Conservative management of placenta accreta: hysteroscopic resection of retained tissues. J Minim Invasive Gynecol 21(5):910–913. https://doi.org/10.1016/j.jmig.2014.04.004
Capote S, Cubo-Abert M, Casellas-Caro M, Sánchez-Iglesias JL, Gomez-Cabeza JJ, Gil-Moreno A (2018) Role of office hysteroscopic morcellation and 3-dimensional transvaginal ultrasound in conservative management of retained placenta accreta. Eur J Obstet Gynecol Reprod Biol 230:199–200. https://doi.org/10.1016/j.ejogrb.2018.09.024
Duan H, Xia E, Zhang M et al (2005) Clinical analysis of 36 cases of complications of hysteroscopic surgery. Chinese J Obstet and Gynecol 40(7):435–437
Fu X, Luo X, Qi H (2013) Clinical study of 22 cases of postpartum placental implantation treated by high intensity focused ultrasound. Chinese J Pract Gynecol Obstet 29(8):649–652
Liu X, He J, Huang G, Zhang L (2015) The safety and efficacy of high intensity focused ultrasound in the treatment of placental increta. J Chongqing Med University 40(9):1260–1263
Bai Y, Luo X, Li Q, Yin N, Fu X, Zhang H (2014) Qi H High-intensity focused ultrasound treatment of placenta accreta after vaginal delivery: a preliminary study[J]. Ultrasound Obstet Gynecol 43(1):98–101. https://doi.org/10.1002/uog.14867
Lee J-S, Hong G-Y, Park B-J, Hwang H, Kim R, Kim T-E (2016) High-intensity focused ultrasound combined with hysteroscopic resection to treat retained placenta accrete. Obstet Gynecol Sci. 59(5):421–425. https://doi.org/10.5468/ogs.2016.59.5.421
Ye M, Yin Z, Xue M, Deng X (2017) High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta. BJOG 124(S3):71–77. https://doi.org/10.1111/1471-0528.14743
Chen D, Yang H (2016) Guidelines for the diagnosis and treatment of placenta accreta spectrum disorder. Chinese J Obstet Emerg (Electronic Editon) 5(1):26–31
Silver RM, Barbour KD (2015) Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am 42(2):381–402. https://doi.org/10.1016/j.ogc.2015.01.014
Wortman AC, Alexander JM (2013) Placenta accreta, increta, and percreta. Obstet Gynecol Clin North Am 40(1):137–154. https://doi.org/10.1016/j.ogc.2012.12.002
Lin Z, Gong C, Huang Q et al (2021) A comparison of results following the treatment of placenta accreta and placenta increta using high-intensity focused ultrasound followed by hysteroscopic resection. Int J Hyperthermia 38(1):576–581. https://doi.org/10.1080/02656736
Dossou M, Debost-Legrand A, Déchelotte P, Lémery D, Vendittelli F (2015) Severe secondary postpartum hemorrhage: a historical cohort. Birth 42(2):149–155. https://doi.org/10.1111/birt.12164
Guan X, Huang X, Ye M, Huang G, Xiao X, Chen J (2022) Treatment of placenta increta with high-intensity focused ultrasound ablation and leaving the placenta in situ: a multicenter comparative study. Front Med (Lausanne) 7(9):871528. https://doi.org/10.3389/fmed.2022.871528
Sentilhes L, Ambroselli C, Kayem G et al (2010) Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 115(3):526–534. https://doi.org/10.1097/AOG.0b013e3181d066d4
He S, Xue M, Jiang J (2021) Early versus late hysteroscopic resection after high-intensity focused ultrasound for retained placenta accreta. Int J Hyperthermia 38(1):257–262. https://doi.org/10.1080/02656736.2021.1887943
Liu CN, Tang L, Sun Y, Liu YH, Yu HJ (2020) Clinical outcome of high-intensity focused ultrasound as the preoperative management of cesarean scar pregnancy. Taiwan J Obstet Gynecol 59(3):387–391. https://doi.org/10.1080/02656736.2021.1887943
Chu G, Liu C, Hu C, Yan K, Wang W, Jia L (2018) Comparative study of clinical efficacy of high-intensity focused ultrasound and uterine artery embolization for adjunctive treatment of cesarean scar pregnancy. Chinese J Obstet Gynecol Pediat 14:547–552
Zhang C, Zhang Y, He J, Zhang L (2019) Outcomes of subsequent pregnancies in patients following treatment of cesarean scar pregnancy with high intensity focused ultrasound followed by ultrasound-guided dilation and curettage. Int J Hyperthermia 36(1):926–931. https://doi.org/10.1080/02656736.2019.1654619
Funding
This project was funded by the Southwest Medical University of Sichuan Province, China [(2018)-ZRQN-091].
Author information
Authors and Affiliations
Contributions
All authors contributed to the study’s conception and design. The integrity of the entire study was guaranteed by PZ. YY, XH, PL, and DP executed the study and collected the data. QS performed the data analysis. YY wrote the first draft of the manuscript which was reviewed by all the other authors. All authors read and approved the final manuscript. All authors contributed to the study’s conception and design.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Ethics approval
This study was performed according to the guidelines of the Helsinki declaration and was approved by the Ethics Committee of Southwest Medical University (No.: KY2022151).
Consent to participate
Informed consent was obtained from all participants included in the study.
Consent to publish
The authors affirm that human research participants provided informed consent for the publication of the images in Figs. 1, 2, 3, and 4.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yuan, Y., He, X., Liu, P. et al. The effectiveness of single ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation in managing placenta accreta spectrum (PAS) disorder. Arch Gynecol Obstet 307, 1037–1045 (2023). https://doi.org/10.1007/s00404-022-06840-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-022-06840-6